https://www.pharmaceutical-technology.com/news/lynparza-ec-approval-breast-cancer/ 2019-04-11T10:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-concerto-healthai-alliance/ 2019-04-11T10:23:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cell-and-gene-therapy-manufacturing-2019/ 2019-04-12T12:06:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-cancer-pipeline/ 2019-04-10T13:12:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/binge-eating-disorders-and-mood/ 2022-12-13T10:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-alnylam-partnership/ 2019-04-10T10:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-amgen-evenity/ 2023-05-15T03:57:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dupixent-atopic-dermatitis-2/ 2019-04-09T14:56:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pancreatic-cancer-treatment/ 2019-04-09T14:08:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asthma-biologic-therapy/ 2022-11-30T14:50:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-daiichi-sankyo-deal-2/ 2019-04-09T11:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/atopic-dermatitis-comorbid/ 2019-04-09T10:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/epigenetics-and-cancer/ 2023-06-02T04:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-cancer-immunotherapy-vaccine/ 2019-04-09T16:13:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-two-drug-dovato-fda-approval/ 2019-04-09T10:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/centene-washington-uni-personalised-medicines/ 2019-04-09T10:31:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cervical-cancer-screening-uk/ 2023-01-11T18:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vascepa-fish-oil-benefits/ 2019-04-12T10:35:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drugs-from-corn-mirexus-phytoglycogen/ 2019-04-09T14:39:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-luspatercept-anaemia-fda-filing/ 2019-04-08T11:09:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-alnylam-rare-disease-alliance-option-phase/ 2019-04-09T09:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-alexion-lundbeck-settle-probe/ 2019-04-08T10:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharmaceutical-supply-chain-hapa/ 2022-07-11T08:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/male-breast-cancer-ibrance-label-expansion/ 2022-12-23T09:18:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-snda-hiv-label-expansion-for-descovy/ 2019-04-05T14:46:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cannabinoid-based-drugs/ 2023-03-30T10:42:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-small-cell-lung-cancer-treatment/ 2019-04-05T11:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-opdivo-yervoy-combination-rcc/ 2019-04-05T09:56:17+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/agomab-fundraising/ 2019-04-05T08:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-amgen-aimovig-dispute/ 2019-04-05T11:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roivant-sinovant-launch-cytovant-sciences/ 2019-04-05T15:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-treatment-2/ 2019-04-04T16:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pharmaceutical-industry-in-india/ 2022-02-11T04:50:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/purdue-pharma-opioid-settlement/ 2019-04-04T15:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-long-term-hiv-juluca-combination/ 2019-04-04T16:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diabetes-type-1-treatment/ 2023-05-24T04:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-disease-treatment/ 2022-08-02T08:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-clinical-trial-universal-influenza-vaccine/ 2022-07-11T08:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biosimilars-clinical-trials/ 2019-04-04T09:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dyne-therapeutics-launch/ 2023-05-02T09:59:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editas-bluerock-cell-medicines-deal/ 2021-11-23T04:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-pfizer-nsclc-drug-vizimpro/ 2019-04-04T10:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/allergic-rhinitis-treatment/ 2022-11-26T08:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/highlights-from-the-14th-international-conference-on-alzheimers-and-parkinsons-diseases-2019/ 2019-04-08T09:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trials-with-monoclonal-antibodies-discussed-at-ad-pd-2019/ 2019-04-03T14:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biggest-generic-pharmaceutical-companies-2018/ 2024-05-10T07:00:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ambar-study-on-new-treatments-for-alzheimers-and-parkinsons-discussed-at-ad-pd-2019/ 2019-04-03T13:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biomarkers-in-oncology/ 2019-04-03T13:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nmpa-approves-two-drugs-cosentyx-keytruda/ 2019-04-03T10:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sangamo-early-results-haemophilia-a-gene-therapy/ 2019-04-03T09:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-resubmits-bla-biosimilar-pegfilgrastim/ 2023-03-08T09:49:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-khloris-anti-cancer-vaccines/ 2021-10-21T11:09:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/puma-pierre-fabre-nerlynx-licensing/ 2019-04-03T08:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-crenezumab-2019/ 2019-04-02T13:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-of-prostate-cancer-diagnosis/ 2019-04-02T11:37:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/springworks-therapeutics-fundraising/ 2023-01-05T06:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zentiva-buys-creo-pharmaceuticals/ 2021-12-02T12:14:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pharmacare-for-all-in-canada-unlikely-proposal-to-imminent-thr-html/ 2021-11-02T03:19:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-migraine-drug-ajovy-europe-approval/ 2022-03-17T03:59:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-selumetinib-breakthrough-therapy-designation/ 2019-04-01T16:00:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/penn-results-targeted-aml-drug-gilteritinib/ 2019-04-01T12:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-buys-ifm-tre/ 2019-04-03T06:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-stridebio-collaboration/ 2023-05-04T05:02:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-zynteglo-chmp-opinion/ 2021-11-23T05:44:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/celgene-exscientia-collaboration/ 2019-03-29T17:07:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/green-pharma-future/ 2019-03-29T16:03:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-imfinzi-cancer-drugs-fund/ 2019-03-29T15:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biomarkers-for-alzheimers/ 2019-03-29T15:05:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/car-t-cell-therapy/ 2019-03-29T13:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galapagos-gilead-phase-iii-filgotinib-rheumatoid-arthritis/ 2019-03-29T12:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimer-drugs-in-clinical-trials/ 2019-03-29T11:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/more-effective-bipolar-treatment-repurposing-drugs/ 2022-12-26T12:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-daiichi-sankyo-deal/ 2019-03-29T11:21:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-cimzia-fda-approval/ 2023-01-19T10:00:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-investment-swiss-biologics-site/ 2019-03-29T10:56:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/accuracy-check-norwegian-health-expenditure-data-html/ 2021-11-02T03:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gender-bias-in-disease-diagnosis/ 2019-03-28T16:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-in-pharma-rd/ 2019-03-28T15:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-digital-cost-of-prescriptions-declines-number-of-items-rises/ 2019-03-28T15:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/microbiome-and-cancer-immunotherapy/ 2019-03-28T15:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-cancer-uk-incidence/ 2019-03-28T12:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clarus-jatenzo-testosterone-replacement-therapy-hypogonadism/ 2019-03-28T11:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/machine-learning-and-iot-poorest/ 2019-12-23T10:54:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jim-oneill-superbugs/ 2019-03-28T12:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-novartis-mayzent/ 2019-03-28T12:03:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-immunext-research-alliance/ 2019-03-28T15:43:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-pharma-investment/ 2019-03-27T17:53:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/improving-ivf-outcomes/ 2019-03-27T17:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ovarian-cancer-drug-trials/ 2022-07-11T08:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/heart-pump-technology-2019/ 2019-03-27T16:40:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blue-brain-project-neurons-structure/ 2019-12-23T10:54:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lees-pharm-regenerx-ophthalmic-drug-china/ 2019-03-27T11:11:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tuberculosis-in-europe/ 2019-03-27T10:00:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-ono-alliance/ 2019-03-28T09:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-japan-approval-skyrizi/ 2022-03-28T07:10:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-pharma-settles-oklahoma-opioid-case/ 2019-03-27T09:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rogue-online-pharmacies-search-engines/ 2019-03-26T17:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-buys-ignyta/ 2019-03-26T17:18:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-of-lung-cancer-testing/ 2019-03-26T16:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytodyn-leronlimab-monotherapy-hiv/ 2021-11-26T05:23:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aimmune-peanut-allergy-drug-primary-endpoint/ 2022-12-09T12:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-q4-2018 2019-03-26T04:08:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-q4-2018 2019-03-27T15:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-february-2019 2019-03-27T15:54:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-february-2019 2019-03-27T15:53:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-jj-775m-xarelto-settlements/ 2021-10-21T11:09:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-forxiga/ 2019-03-26T09:38:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arch-oncology-funding-round/ 2019-04-03T08:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/peripheral-artery-disease-treatment/ 2019-03-25T17:02:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmamar-lurbinectedin-primary-endpoint-sclc/ 2023-01-04T11:07:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-triple-combination-bowel-cancer-drug-resistance/ 2019-03-25T11:54:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/china-pharma-success-government-policy/ 2019-12-23T10:54:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-darzalex-ema-submission/ 2019-03-25T10:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-buys-brammer-bio/ 2021-11-01T08:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-drug-combo-paediatric-brain-tumour/ 2019-03-25T10:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genomics-england-immunotherapy-for-cancer/ 2019-12-23T10:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-relugolix/ 2019-03-22T12:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-eisai-alzheimers-drug-trial-terminated/ 2022-07-11T08:55:16+00:00 daily 2.0 https://www.pharmaceutical-technology.com/analyst-comment/who-universal-flu-vaccine-2019-2030/ 2023-05-10T05:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-recalls-sartan-medication/ 2019-03-22T10:35:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sunosi-fda-approval-jazz-pharma/ 2019-03-22T09:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-hemoshear-liver-partnership/ 2019-03-22T16:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/counterfieit-drugs-medicines/ 2019-12-23T10:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/colegene-exscientia-ai-drug-discovery/ 2019-12-23T10:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/advantages-of-5g/ 2019-12-23T10:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-the-absence-of-antivenom-in-pharma/ 2019-03-21T15:47:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-ai-drug-discovery-partnership-exscientia/ 2019-12-23T10:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-safety-warning-xeljanz-rheumatoid-arthritis/ 2019-03-21T11:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-deals-in-february-2019 2019-03-22T05:39:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/arthritis-in-women/ 2022-11-29T15:40:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/uk-pharma-industry-deals-in-q4-2018 2019-03-22T05:33:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/china-pharma-industry-deals-in-q4-2018 2021-11-23T08:21:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-and-depression/ 2022-11-29T15:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inhalable-oxytocin/ 2021-10-29T05:20:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-buys-vivet-therapeutics-stake/ 2023-06-15T04:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-ngm-bio-alliance-extension/ 2019-03-21T10:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-tesaro-endometrial-cancer-dostarlimab/ 2019-03-20T14:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatitis-c-infection-prevalence/ 2019-03-20T14:48:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-prostate-cancer-treatment/ 2019-03-20T12:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dengue-vaccine-initiative/ 2019-03-20T12:26:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/amanda-feilding-medical-cannabis-psychedellics-reform/ 2019-03-20T12:23:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-roche-fda-halts-multiple-myeloma-trial/ 2022-07-11T08:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sage-zulresso-gets-fda-approval/ 2019-03-20T12:00:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brexit-medicines-supply-risk-eu/ 2019-03-20T12:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/twoxar-ono-pharmaceutical-partnership/ 2019-12-23T10:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-tecentriq-oncology-roche/ 2019-03-19T14:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatitis-c-drug-pricing/ 2019-03-19T13:38:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-label-allergan-antibacterial-avycaz/ 2019-03-19T12:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/future-of-work-2019/ 2019-12-23T10:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cybersecurity-breach-pay/ 2019-12-23T10:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-treatment-2/ 2022-11-29T15:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hemophilia-treatments/ 2019-03-19T11:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pistoia-alliance-european-conference-importance-of-data/ 2019-12-23T10:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nintedanib-approval-boehringer-ingelheim/ 2019-03-19T11:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-teva-victoza-patent-dispute/ 2019-03-20T11:15:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-gardp-partnership/ 2019-03-19T14:19:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acne-rosacea-treatment/ 2023-05-19T03:54:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergy-therapeutics-birch-pollen/ 2019-03-18T15:39:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-venture-financing-deals-in-february-2019 2019-03-19T14:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-february-2019 2019-03-19T14:34:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/api-pharma/ 2019-03-18T17:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/life-sciences-funding/ 2019-07-08T09:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nasa-virus-reactivation-spaceflight-vaccination-development/ 2019-03-18T11:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/triple-negative-breast-cancer/ 2019-03-18T11:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ckd-mbd-treatment/ 2019-03-18T10:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blackstone-acquire-ayumi-pharmaceutical/ 2019-03-18T12:49:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-keytruda-metastatic-squamous-nsclc/ 2019-03-18T12:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-fda-saracatinib-ipf/ 2023-01-30T14:55:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/how-close-are-we-to-finding-a-cure-for-hiv/ 2019-03-15T15:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-roche-mabthera-pv/ 2023-05-30T03:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hiv-injections-viiv-healthcare/ 2019-03-26T09:37:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/keytruda-cancer-drug/ 2019-03-15T10:06:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/pharma-deal-activity-for-q4-2018-reaches-21-11bn 2022-01-03T10:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/german-carb-x-partnership/ 2019-03-15T11:41:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hemlibra-haemophilia-approval/ 2019-03-15T10:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-gates-foundation-partnership/ 2019-03-20T10:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/firrma-pilot-program/ 2019-04-02T11:31:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/migraleve-uk-supply/ 2020-01-31T13:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/what-is-biomanufacturing/ 2020-01-16T10:03:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-acquisitions/ 2019-03-14T14:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stanford-researchers-existing-drug-mitigate-trastuzumab-side-effects/ 2019-03-14T12:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/brexit-impact-on-cybersecurity-to-be-considerable-and-immediate/ 2022-02-03T09:08:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/future-of-semiconductor-industry-ten-companies-predicted-to-succeed/ 2019-12-23T10:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/the-us-pharma-industry-ma-deals-in-q4-2018 2019-03-15T05:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/the-us-pharma-industry-venture-financing-deals-in-q4-2018 2019-03-15T05:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deerfield-harvard-partnership/ 2019-03-14T12:54:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antifungal-amphotericin-cystic-fibrosis/ 2019-03-14T11:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advances-in-kidney-disease-and-treatment-stem-cells/ 2022-11-29T15:37:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/psoriasis-treatment-abbvie/ 2019-03-13T16:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cardiovascular-market-top-drivers/ 2021-11-22T06:17:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-orphan-drugs-rare-diseases/ 2019-03-13T14:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novavax-rsv-vaccine-failure/ 2019-03-13T12:08:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/s-aureus-biomarker-atopic-dermatitis/ 2019-03-13T11:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/cloud-computing-healthcare/ 2019-12-23T10:50:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-pricing-hearing-pharmacy-benefit-managers/ 2019-03-13T17:12:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parkinsons-disease-research/ 2019-03-13T10:22:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trazimera-fda-approval/ 2022-02-14T08:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brussels-attracts-uk-pharma-business/ 2019-03-14T11:20:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/conference-puts-orphan-drug-funding-centre-stage/ 2019-03-12T16:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/future-of-servers-storage-and-networks-ten-companies-predicted-to-succeed/ 2023-01-06T07:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/geneuro-ms-drug-neuroprotective-two-year-study/ 2019-03-12T12:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/transport-of-medical-products-no-deal-brexit/ 2019-03-12T11:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-to-begin-selling-rapid-acting-insulin-generic/ 2022-03-15T06:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-sells-biologics-site/ 2019-03-12T16:03:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-seres-therapeutics-alliance/ 2019-03-12T11:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/microsoft-platform-therapies-production/ 2019-03-12T12:27:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/budget-impact-of-sharing-rebates-html/ 2021-11-02T03:21:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nhs-rpa-digital-robot-trial-2/ 2019-12-23T10:55:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-global-influenza-strategy/ 2023-03-31T10:43:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/approval-of-humira-in-japan-expected-to-bolster-abbvies-bottom-line/ 2023-03-20T15:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/microrobots-medical-nanotechnology/ 2022-02-03T02:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/future-of-neurology-uncovering-new-treatment-approaches/ 2019-03-11T10:11:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takedas-entyvio-superior-remission-humira-ulcerative-colitis/ 2019-05-20T13:31:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/priority-review-sanofi-dupixent/ 2023-03-23T06:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parp-inhibitors-boost-immunotherapy/ 2019-03-11T15:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-pain-medications-deal/ 2019-03-11T09:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/technology-in-digital-transformation/ 2019-12-23T10:50:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/rsv-vaccine-nanoparticles/ 2019-12-23T10:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nemolizumab-shows-promise-in-phase-iib-trials-in-atopic-dermatitis/ 2023-06-26T05:45:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-private-equity-deals-in-q4-2018 2019-03-08T13:07:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-january-2019 2019-03-20T15:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-q4-2018 2019-03-08T13:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-venture-financing-deals-in-january-2019 2019-03-08T13:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-venture-financing-deals-in-q4-2018 2019-03-08T13:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hiv-1-monthly-regimen-janssen-viiv/ 2019-03-08T12:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cyberattack-traffic/ 2019-12-23T10:57:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/machine-learning-model-lung-cancer/ 2019-12-23T10:54:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biosimilars-diabetes-and-hcv-drug-uptake-to-spike-under-us-government-proposed-changes/ 2019-03-08T10:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-tecentriq-combo-nsclc-approval/ 2019-03-11T09:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gtx-oncternal-therapeutics-merger/ 2019-03-08T12:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/facebook-curbs-vaccine-misinformation/ 2019-06-27T14:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-pharmaceutical-companies/ 2024-05-08T10:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-england-calls-vertex-an-extreme-outlier-in-conduct-of-orkambi-negotiations/ 2019-03-07T17:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-jpmorgan-berkshire-hathaway-joint-venture-announced/ 2019-03-07T12:22:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beam-therapeutics-crispr/ 2019-03-07T12:19:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-fedratinib-fda-myelofibrosis-review/ 2019-03-07T17:23:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-ambrx-biologics-alliance/ 2019-03-07T12:08:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/grilling-of-vertex-boss-by-mps-may-have-eu-wide-ramifications/ 2019-03-06T17:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/christensella-the-key-to-unlocking-gut-microbiome-based-drug-discovery/ 2020-01-31T13:50:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-cystic-fibrosis-triple-combination/ 2019-03-06T14:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aravax-takes-a-step-closer-to-developing-a-peanut-allergy-vaccine/ 2019-03-06T12:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scott-gottlieb-resigns-as-fda-commissioner/ 2019-03-06T11:20:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-janssen-depression-drug-spravato/ 2019-03-06T12:35:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/diabetes-immunotherapy-pfizer-antoirx/ 2019-03-06T12:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/promacta-intellectual-property-rights/ 2019-03-07T05:04:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-treatment-approach-hiv-remission/ 2019-03-05T15:50:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-frontier-in-treatment-of-triple-negative-breast-cancer/ 2019-03-05T12:50:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/no-link-between-mmr-vaccination-and-autism/ 2019-03-05T11:43:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-things-are-expected-for-rna-in-2019/ 2019-03-13T11:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orion-bayer-seek-darolutamide-japan/ 2019-03-05T14:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/february-2019-top-news-stories-pharma/ 2019-03-07T07:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nantkwest-promab-immunotherapy/ 2019-03-05T16:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-insulin-lispro/ 2019-03-05T10:00:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trends-in-high-value-injectables-packaging/ 2019-03-13T11:06:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/brexit-risks-disruption-of-uk-medicines-destined-for-eu/ 2019-03-13T11:03:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-chmp-recommends-medicines-for-approval/ 2022-11-24T12:11:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/parkinsons-disease-is-on-the-rise-in-every-region-of-the-planet/ 2019-03-05T09:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/patent-expiration-explains-pick-up-in-biosimilars-market/ 2019-03-04T13:23:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/celiac-disease-pipeline-is-small-but-innovative/ 2023-11-06T05:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-carcinogenic-impurity-recallarb-blood-pressure-drugs/ 2019-03-04T11:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/multiple-myeloma-continues-to-be-characterised-by-its-unmet-needs/ 2019-03-04T10:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/auden-waymade-hydrocortisone-deal/ 2019-03-04T10:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-buys-nightstar-therapeutics/ 2019-03-04T17:06:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-lynparza-breast-cancer-eu/ 2019-03-04T12:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-ma-deals-for-january-2019 2019-03-15T06:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-venture-financing-deals-for-january-2019 2019-03-15T06:23:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ransomware-drop/ 2019-12-23T10:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-warns-canarx-unapproved-medicines-us/ 2019-03-01T15:18:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/what-are-the-benefits-of-nanobodies/ 2019-03-01T14:29:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/orphan-drug-development-in-china/ 2019-03-01T14:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-biomarkers/ 2019-03-01T14:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-deals-in-january-2019 2019-03-01T14:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-giant-partners-with-ibm-to-bring-blockchain-to-clinical-trials/ 2022-07-11T08:55:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/third-rock-maze-191m-genetic-research/ 2019-03-07T10:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-celgene-acquisition/ 2019-03-04T05:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-curevac-vaccine-printing-platform/ 2019-03-01T11:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-provides-a-more-intelligent-approach-to-ovarian-cancer-treatment/ 2019-02-28T13:07:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/britain-risks-thousands-of-heart-disease-and-stroke-deaths-due-to-brexit/ 2019-02-28T12:56:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trumps-effort-to-cut-healthcare-costs-fails-as-americans-cross-the-border-to-buy-insulin-in-mexico/ 2019-03-13T13:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diffuse-large-b-cell-lymphoma-pipeline-more-car-t-approvals-imminent/ 2019-02-28T12:38:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-therapy-areas-in-biosimilar-trials/ 2022-07-11T08:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-acquire-myonexus-165m/ 2019-02-28T11:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/treatment-for-rare-diseases-2019-calliditas-nefecon/ 2023-05-29T04:35:23+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/ai-datathon-repurpose-five-drugs-chronic-pancreatitis/ 2023-01-04T11:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bausch-health-buys-synergy-pharmaceuticals/ 2021-10-31T14:27:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-blackstone-anthos-therapeutics/ 2019-03-01T06:02:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-tremfya-injector-fda-approval/ 2019-03-20T16:04:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-rare-diseases-genomic-medicine/ 2019-12-23T10:50:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-esperoct-launch/ 2019-02-27T14:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/obesity-pipeline/ 2023-01-19T09:58:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oyster-point-raises-93m-in-financing-round-to-fund-ded-pipeline/ 2019-02-27T13:10:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/single-use-plastics-pharma/ 2020-01-16T10:03:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-executives-high-prices-hearing/ 2019-02-27T12:27:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brexit-nhs-impact/ 2019-02-27T09:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/direct-gdnf-infusion-parkinsons/ 2019-02-27T14:10:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-pbms/ 2019-02-26T16:27:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-opioid-crisis-google/ 2019-02-26T14:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ucb-epilepsy-society-partnership/ 2021-11-30T12:07:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/department-of-health-no-deal-brexit-preparations/ 2019-02-27T05:14:34+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/castleman-disease-machine-learning-cdcn-medidata/ 2019-12-23T10:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-divests-biopharma-business/ 2019-02-26T11:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-buys-clementia-pharmaceuticals/ 2019-02-26T10:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-regeneron-amgen-repatha-patents/ 2019-02-26T14:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hiv-trials-2018/ 2019-02-25T18:21:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-exercises-rights-to-ionis-cv-drug-tqj230/ 2021-12-02T12:11:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-of-abbvie-s-humira/ 2019-02-25T15:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vaccines-and-social-media/ 2019-02-25T17:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-top-threats-to-global-health-2019-solutions/ 2019-02-25T16:20:35+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/astrazeneca-brilinta-mace-cad-type-2-diabetes/ 2019-02-25T10:35:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-biomarin-brineura/ 2023-03-23T11:07:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/delsitech-leveraging-silicas-properties-to-improve-drug-delivery/ 2019-12-23T10:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-acquires-spark-therapeutics/ 2019-02-25T14:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-voyager-deepen-alliance/ 2019-02-25T12:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/flugen-success-brings-the-reality-of-universal-influenza-vaccines-closer/ 2019-02-22T16:53:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/anti-vaxxers-on-facebook/ 2019-12-23T10:50:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/powdered-air-purifying-respirator/ 2020-01-16T10:04:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ms-is-more-prevalent-in-the-us-than-previously-reported/ 2019-02-22T16:08:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/renal-cancer-patient-enrolment-takes-a-hit/ 2019-02-22T15:22:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-drugs-researched-for-treatment-of-asthma/ 2019-02-22T14:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucsf-discover-potential-new-treatment-approach-for-type-1-diabetes/ 2019-03-03T11:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquires-immune-design/ 2019-02-22T11:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/morphic-therapeutic-janssen-deal/ 2019-02-22T11:23:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outcome-based-payment-cancer-drugs-cancer-research/ 2019-02-22T11:23:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/moderna-ipo-mrna/ 2019-02-21T17:25:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-japan-pharma-growth/ 2019-02-21T14:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xencor-study-halted-xmab14045-acute-myeloid-leukaemia/ 2019-02-21T13:06:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-healthcare-spending-2027/ 2022-07-18T10:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomx-series-b-round/ 2019-02-21T13:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-fda-nod-esperoct/ 2019-02-21T10:16:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mercks-infant-vaccine-earns-fda-breakthrough-designation-threatening-pfizers-dominance/ 2019-02-21T09:46:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/health-check-scottish-pharma-industry/ 2019-02-22T10:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-scottish-pharma-gets-a-health-check/ 2019-02-20T15:21:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-of-dundee-takeda-tau-pathology-drug-development/ 2019-02-20T15:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-international-comparison-health-of-young-people/ 2019-02-20T12:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-digitising-clinical-trials/ 2022-07-11T08:55:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indivior-launches-generic-suboxone/ 2021-12-02T06:52:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-review-abbvie-upadacitinib/ 2019-02-20T09:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-takedas-alunbrig-brigatinib-nsclc/ 2023-06-20T04:40:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/knight-moksha8-deal-investment/ 2021-12-02T09:21:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gileads-lead-liver-disease-candidate-may-still-have-a-future-despite-phase-iii-failure/ 2023-06-01T10:41:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-priority-review-entrectinib-polatuzumab/ 2019-02-19T13:40:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-radiotherapy-plan-reduce-side-effects/ 2019-02-19T10:21:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-chipscreen-biosciences-deal/ 2019-02-19T12:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/self-driving-cars-have-miles-to-full-autonomy/ 2019-12-23T10:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aklrd-awarded-675000-grant-from-innovate-uk/ 2019-02-18T15:41:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/conjunctivitis-treatment/ 2019-02-18T14:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ocaliva-poses-enrolment-obstacle-in-liver-disease-clinical-trials/ 2022-11-24T12:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-merck-group-results-rcc-combination-therapy/ 2019-02-18T11:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharmaceutical-manufacturing-scale-up/ 2020-01-16T10:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/jetmixer-powder-liquefying/ 2020-01-16T10:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-roche-pertuzumab/ 2019-02-18T11:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-buys-gsk-chiron-behring/ 2019-02-18T11:12:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-closes-loxo-oncology-acquisition/ 2019-02-18T11:16:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sarepts-nda-for-golodirsen-precision-medicine/ 2019-02-15T14:49:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-world-is-getting-better-look-no-further-than-vaccines/ 2019-02-15T12:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-trials-keytruda-prostate-cancer/ 2022-07-11T08:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/passage-bio-launch/ 2021-11-24T03:44:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-new-us-company/ 2021-12-02T06:16:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/molecules-reverse-memory-loss/ 2019-02-15T12:08:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-breakthrough/ 2022-02-21T07:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/atopic-dermatitis-treatment/ 2022-12-28T14:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-biopharmaceuticals-arvelle-partnership-epilepsy-drug-cenobamate/ 2019-02-14T14:50:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-treatments-erectile-dysfunction/ 2024-05-10T07:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-abcellera-antibody-technology-multi-target-partnership/ 2021-11-22T12:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/decoy-platelets-clots-cancer-spread/ 2019-02-14T11:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-ema-approval-fycompa/ 2019-02-14T11:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neurogene-raises-funds/ 2019-02-14T09:32:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gdpr-and-brexit/ 2019-12-23T10:57:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/treatment-for-broken-heart-syndrome/ 2020-01-31T13:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-recall-sartan-based-products/ 2019-03-04T09:32:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dementia-consortium-new-partners-drug-discovery/ 2021-12-03T10:04:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/top-ten-healthcare-sector-financial-legal-advisers-2018/ 2019-02-13T17:32:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-panel-janssen-esketamine-nasal-spray/ 2019-02-13T10:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-expands-takeda-adcetris-authorisation/ 2019-02-13T09:28:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-divests-proleukin-us-rights/ 2021-11-22T07:13:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/blockchain-smart-manufacturing-security/ 2019-12-23T10:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-spend-investment/ 2019-12-23T10:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/checkered-data-hinders-reatas-bardoxolone-phase-ii-prospects/ 2023-05-04T04:59:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-merck-keytruda-priority-review-first-line-therapy-hnscc/ 2022-02-08T13:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/psoriasis-treatment/ 2022-03-29T11:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clamps-down-illegal-dietary-supplements/ 2019-02-12T14:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pnh-treatment/ 2019-02-12T13:11:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-muscle-invasive-bladder-cancer/ 2019-02-12T10:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-teneobio-multiple-myeloma-deal/ 2019-02-12T11:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-pfizer-bavencio-inlyta-sbla/ 2019-02-20T10:24:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-epilepsy-society-targeted-treatments/ 2023-05-31T04:52:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/united-states-experience-dramatic-shift-public-healthcare-html/ 2021-11-02T03:21:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-withdraws-rna-collaboration-arcturus/ 2019-02-11T16:10:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cholesterol-lowering-drugs/ 2023-05-09T07:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-sanofi-cut-us-list-price-of-praluent/ 2019-02-11T15:34:07+00:00 daily 1.0 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-treatment/ 2022-11-29T15:40:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharmaceutical-packaging-in-2019-the-view-from-origins-rich-quelch/ 2023-05-12T11:15:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/antibiotics-research-antismash/ 2019-02-06T14:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-china-expansion/ 2019-02-11T12:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/finch-therapeutics-c-difficile-drug/ 2019-02-11T11:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/january-2019-top-news-stories-pharma/ 2019-03-05T12:32:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-japan-recalls-valsartan-drug/ 2019-02-11T11:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sangamo-herapeutics/ 2021-11-22T06:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/stroke-research-2018/ 2022-12-20T10:25:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/immuno-oncology-sees-solid-growth-spurt/ 2023-02-28T04:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-cancer-drug-new-mechanism-of-action/ 2019-02-08T15:01:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/heart-power-recharge-medical-devices/ 2019-02-08T14:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cryptocurrency-free-blockchain-yosemite/ 2019-12-23T10:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/securityscorecard-ngos-cybersecurity/ 2019-12-23T10:57:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ophthalmology-drug-innovation-is-stuck-in-the-slow-lane/ 2023-06-27T04:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/positive-outcomes-for-neurology-despite-setbacks-for-alzheimers-disease/ 2019-02-08T12:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insulin-delivering-drug-capsule/ 2019-02-08T09:30:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-and-johnson-drug-prices-tv-ads/ 2019-02-08T12:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/no-deal-brexit-falsified-medicines-directive/ 2019-02-08T11:11:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fate-therapeutics-pluripotent-stem-cell-therapy-ind/ 2021-11-22T10:16:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-petri-dish-telling-the-story-of-pharmas-most-humble-ally/ 2023-05-29T05:28:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-galapagos-collaboration/ 2019-02-07T16:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiho-pharmaceutical-cullinan-deal/ 2019-02-07T11:29:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sanofi-cablivi/ 2019-02-07T09:34:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xencor-genentech-partner-il-15-cytokine-drugs/ 2019-02-06T16:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-virtual-library-docked-molecules-drug-discovery/ 2019-12-23T10:51:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-merck-m7824-immunotherapy/ 2019-02-06T11:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fsd-pharma-pharma-grade-cannabinoids/ 2019-02-06T14:39:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-kadcyla-us-application/ 2019-02-06T09:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-gene-therapy/ 2019-02-05T17:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ibm-cyber-tactical-operations-center/ 2019-12-23T10:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/automation-working-week/ 2019-12-23T10:55:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-discover-new-drug-target-to-control-cancer-cell-growth/ 2019-02-05T15:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-myeloma-drug-primary-endpoint/ 2019-02-05T15:36:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cancer-in-young-adults/ 2019-02-05T13:25:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/takedas-dengue-milestone-is-a-time-for-cautious-optimism/ 2019-02-05T12:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-cancer-day-2019/ 2019-02-05T12:11:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-treatment/ 2019-02-05T11:43:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-drug-prices-second-hearing/ 2019-02-05T09:34:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/argenx-uses-halozyme-enhanze-technology/ 2021-11-22T06:16:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-rsv-drug-medi8897/ 2019-02-05T14:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lhon-eye-drug-endpoint-phase-iii/ 2019-02-04T15:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tackling-consequences-air-pollution-drug-rd/ 2019-02-04T14:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cancer-drug-prices-2019/ 2019-02-04T11:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pricing-dispute-orkambi/ 2019-02-04T11:54:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-cancer-day-therapies-rare-cancers/ 2023-06-02T04:10:37+00:00 daily 1.0 https://www.pharmaceutical-technology.com/sponsored/safeguarding-against-biopharmaceutical-contamination/ 2020-01-16T10:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharmaceutical-manufacturing-containment-single-use/ 2020-01-16T10:05:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-depression-drug-additional-data/ 2021-12-01T13:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indivior-sells-sai-bo-song-rights/ 2019-02-04T12:43:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-migraine-drug-ajovy-chmp-nod/ 2019-02-04T12:34:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/combination-cancer-therapies/ 2019-03-05T17:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/comply-with-gdpr-business-leaders/ 2019-12-23T10:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/virtual-reality-market-worth-2024/ 2019-12-23T10:51:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-nhs-kymriah-second-indication-dlbcl/ 2019-02-01T14:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-funding-post-shutdown/ 2019-02-01T14:06:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/2019-jp-morgan-healthcare-conference/ 2019-07-08T09:01:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/checkpoint-inhibitor-targets/ 2019-02-01T11:41:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gen-z-survey-technology/ 2019-12-23T10:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/disruptive-technology-coeus-survey/ 2019-02-01T11:11:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/facial-recognition-ibm/ 2019-12-23T10:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/future-of-iot-benefits-risks/ 2019-12-23T10:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/causes-of-trial-termination/ 2019-01-31T12:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-advair-generic-approval/ 2019-02-01T12:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-strides-pharma-science-lambda-therapeutic-research-nextpharma/ 2021-11-22T09:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-targets-drug-rebates/ 2019-02-01T14:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-meiragtx-deal/ 2023-03-30T10:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-medicines-for-malaria-venture-swedish-orphan-biovitrum-atyr-pharma/ 2019-02-04T15:43:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-is-the-global-pharma-industry-fighting-the-rise-of-chronic-respiratory-illnesses-find-out-in-the-latest-issue-of-pharma-technology-focus/ 2019-02-04T10:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anti-ageing-startups/ 2019-01-31T14:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pancreatic-cancer-treatment-options/ 2022-10-14T12:54:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/setback-for-first-in-class-drug-aimovig/ 2019-01-31T12:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/late-stage-sma-pipeline-could-threaten-biogens-spinraza/ 2019-01-31T12:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-idmc-recommends-janssen-erleada-mcspc/ 2019-01-31T12:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-supply-chain-security-ai-blockchain/ 2022-07-11T08:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-lilly-novo-insulin-prices-enquiry/ 2019-01-31T09:35:05+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/uk-aims-hiv-transmissions-end/ 2019-01-31T12:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-pneumococcal-vaccine/ 2019-01-31T09:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orphazyme-results-arimoclomol-npc/ 2019-01-30T15:36:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/angioedema-treatment-ruconest/ 2023-03-31T10:37:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm-healthcare-conference-key-themes/ 2019-01-31T12:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/therapies-for-ent-disorders/ 2019-01-30T12:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-data-dengue-vaccine-study/ 2019-01-30T11:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uterine-cancer-and-obesity/ 2019-01-30T09:59:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/voyager-neurocrine-deal/ 2021-12-02T07:41:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-partners-triphase/ 2019-01-30T14:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agenus-issues-digital-token/ 2019-12-23T10:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/survey-quality-professionals-prioritise-performance/ 2019-01-29T14:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mmv-dndi-pandemic-response-box/ 2019-01-29T14:13:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/horizon-discovery-rutgers-alliance/ 2019-01-29T14:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-janssen-imbruvica-fda-approval/ 2019-01-29T10:32:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alivio-partners-purdue-pharma-non-opiod/ 2022-03-29T11:34:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biologics-for-psoriasis/ 2019-01-28T15:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/car-t-therapy-lymphoma/ 2019-01-28T15:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ehlers-danlos-syndrome-treatment/ 2019-01-28T13:27:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pompe-disease-treatment/ 2023-01-04T10:10:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-headquarters-london-amsterdam-brexit/ 2019-01-28T12:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-cancer-pills/ 2023-03-20T12:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genetically-modified-chicken-eggs/ 2019-01-28T13:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-synagis-us-rights-sobi/ 2019-01-28T12:37:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-stockpiles-medicines/ 2021-11-02T07:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-halting-lilly-lartruvo/ 2023-01-11T17:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-startup-best-city/ 2019-01-25T13:23:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/5g-dangers-new-networks-bring-host-new-security-concerns/ 2023-02-10T12:39:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/50-million-tonnes-of-ewaste-could-triple-by-2050/ 2019-12-23T10:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/twitter-ai-automation/ 2019-12-23T10:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/out-of-date-pc-applications/ 2019-12-23T10:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-yervoy-combination-nsclc/ 2019-01-28T06:19:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/digital-age-leadership-traits-personas/ 2019-12-23T10:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/business-malware-2018-malwarebytes/ 2019-12-23T10:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/startups-to-watch-in-2019/ 2019-12-23T10:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-halts-cancer-cells-growth/ 2019-01-25T09:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fluzone-quadrivalent-vaccine/ 2019-01-25T10:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/ 2019-01-25T09:47:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bia-record-year-uk-biotech/ 2019-01-24T16:30:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-funding/ 2019-01-24T09:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bridgebio-pharma-funding-round/ 2021-11-23T11:40:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-tackles-antimicrobial-resistance/ 2019-01-24T10:36:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-biosimilar/ 2019-01-23T17:17:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/peptidream-shionogi-peptide-drug-conjugate-deal/ 2019-12-23T10:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspirin-increases-bleeding-risk/ 2019-01-23T12:31:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-blincyto-expanded-indication-europe/ 2022-02-14T08:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-closes-tesaro-deal/ 2019-01-25T14:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/control-spread-of-breast-cancer-metastasis/ 2019-01-23T06:35:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-drug-discovery/ 2022-11-11T11:01:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-medison-pharma-onpattro-israel/ 2019-01-22T12:26:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antiepileptics-hospital-days-alzheimers/ 2019-01-22T14:12:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-vertex-orkambi/ 2019-01-22T10:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/microsoft-walgreens-deal/ 2019-01-21T17:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-kinaxis-technology-supply-chains/ 2022-07-11T08:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/royal-society-guidance-combined-hormonal-contraception/ 2019-01-21T15:10:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-medicines-supply-plans/ 2019-01-21T12:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ontruzant-fda-approval/ 2019-01-21T12:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-university-of-oxford-partnership/ 2019-12-23T10:54:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/survey-efficacy-of-bont-a-treatment-spasticity/ 2019-01-18T15:31:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lenalidomide-approved-in-china-multiple-melanoma/ 2021-10-27T12:49:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/top-ten-influencers-in-blockchain/ 2019-12-23T10:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/collection-1-data-breach/ 2019-12-23T10:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/digital-health-investment/ 2019-12-23T10:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/amazon-largest-company/ 2019-12-23T10:51:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/solid-biosciences-dmd-clinical-trials/ 2022-07-11T08:55:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/next-generation-blockchain-devvio/ 2019-12-23T10:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/crypto-exchange-hacks-bitcoin-price/ 2019-12-23T10:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/energy-quantum-computing-exxonmobil-ibm/ 2019-12-23T10:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cryptohopper-cryptocurrency-trading-bot/ 2019-12-23T10:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/health-data-consortium-eu-investment/ 2019-12-23T10:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vera-digital-personal-shopping-assistant/ 2019-12-23T10:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/iot-security-cyber/ 2019-12-23T10:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-in-the-workplace/ 2019-12-23T10:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sotagliflozin-split-fda-panel-verdict/ 2019-01-21T10:57:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acrotech-biopharma-buys-spectrum-drugs/ 2019-01-18T11:14:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/proteus-digital-oncology-medicines/ 2019-12-23T10:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-prokidney-quest-products-gencore-pacific/ 2019-01-22T09:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-sanofi-knight-therapeutics-ascletis-pharma/ 2019-01-22T09:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/rpa-adoption-medium-sized-businesses-2/ 2019-12-23T10:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bremelanotide-fda-approval/ 2022-11-30T14:32:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-unaware-financial-interests-patient-groups/ 2019-01-17T14:41:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-generic-sabril-us-approval/ 2019-01-17T13:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharma-industry-brexit-deal/ 2019-01-17T12:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-licences-luye-pharma-cholesterol-drug/ 2021-11-22T08:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-policies-for-cell-and-gene-therapies/ 2019-01-18T15:14:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ibm-minehub-blockchain-supply-chain/ 2019-12-23T10:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/robots-in-drug-manufacturing/ 2022-02-03T02:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-drug-pricing-probe/ 2019-01-16T11:59:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-purdue-seek-lemborexant-approval/ 2019-01-16T14:12:01+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/sanofi-biomunex-antibodies-deal/ 2019-01-16T11:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myasthenia-gravis-catalyst-firdapse/ 2023-06-02T04:11:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/should-the-fda-go-independent/ 2019-01-15T12:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/universal-flu-vaccine-development/ 2019-01-15T11:58:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bms-celgene-deal/ 2019-01-15T11:34:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascletis-pharma-alphamabs-partnership/ 2021-11-23T08:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-pfizer-tafamidis-nda/ 2019-01-15T10:21:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/knight-therapeutics-puma-biotech-deal/ 2019-01-14T09:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-japan-partnership-degenerative-diseases/ 2019-01-14T09:45:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-fund-fights-aids-tb-malaria/ 2019-01-14T11:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ethereum-classic-attack/ 2019-12-23T10:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/botox-competitor-jeuveau/ 2024-07-23T11:25:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/second-chance-for-opioid-users/ 2019-12-23T10:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sumitomo-dainippon-results-lead-drug-latuda/ 2021-10-27T12:40:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/robot-delivery-dog-continental/ 2021-10-22T05:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/childhood-vaccines-in-the-us/ 2019-01-11T14:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-us-bills-cut-drug-prices/ 2019-01-11T12:13:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-takeda-eli-lilly-claudio-bidco/ 2019-01-14T09:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/common-drugs-treating-mental-illness/ 2019-01-11T11:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-sanofi-biogen-janssen-pharmaceuticals/ 2019-01-14T09:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-declines-novartis-aimovig/ 2019-01-11T10:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/celgene-acquisition-bms/ 2021-08-27T11:30:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canbridge-wuxi-biologics-partnership/ 2019-01-10T12:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-sponge-soaks-up-chemotherapy-effects/ 2022-08-17T11:28:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/loreal-skin-ph-sensor/ 2019-12-23T10:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sophia-genetics-investment/ 2019-12-23T10:55:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/exoskeletons-lower-limb-paralysis/ 2019-12-23T10:51:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/mobilehelp-ai-carer/ 2019-12-23T10:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-novartis-crizanlizumab/ 2019-01-09T14:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-japanese-approval/ 2019-01-09T12:01:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-tuberculosis-treatment/ 2023-02-27T05:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chronic-urticaria-clinical-trial/ 2022-07-11T08:55:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ultra-pure-synthetic-cannabinoids/ 2019-01-08T15:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-cytoreason-immune-system-model/ 2022-09-21T11:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-closes-shire-acquisition/ 2019-01-10T12:12:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/lilly-acquires-loxo-oncology/ 2019-01-08T09:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-stelara-application-uc/ 2019-01-08T10:45:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-long-term-plan-randd-technology/ 2019-12-23T10:55:52+00:00 daily 1.0 https://www.pharmaceutical-technology.com/uncategorized/driving-jobs-automation/ 2019-12-23T10:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/2019-cryptocurrency-market/ 2019-12-23T10:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/technology-productivity-2019/ 2019-12-23T10:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hpv-vaccination-trends/ 2019-01-07T15:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-outlook-2019/ 2019-01-07T13:44:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-of-continuous-cell-reactor-manufacturing/ 2019-01-07T12:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-ngm-biopharmaceuticals-deal/ 2021-11-22T13:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-regeneron-immuno-oncology-deal/ 2022-11-03T05:16:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-c4-therapeutics-deal/ 2019-03-04T12:48:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/continuous-flow-technologies/ 2022-02-03T02:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oncology-drug-development-bms/ 2019-01-04T15:26:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/flex-and-salarius-cancer-therapies/ 2019-01-04T14:41:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-codiak-collaborate-engineered-exosomes-for-cancer/ 2019-01-04T11:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/data-overload-turning-challenges-into-opportunities-in-clinical-trials/ 2022-07-11T08:55:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/solving-clinical-research-challenges-an-it-perspective/ 2019-01-04T11:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-locus-biosciences-deal/ 2019-01-04T13:29:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-boosts-immuno-oncology-portfolio/ 2019-01-04T12:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-eqt-sanofi-bristol-myers-squibb/ 2021-11-22T06:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ironwood-allergan-mylan-linzess-litigation/ 2019-01-04T10:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/blockchain-jobs-brexit/ 2019-12-23T10:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/funding-next-gen-drugs/ 2019-01-03T16:59:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-celgene-acquisition-74bn/ 2019-01-03T14:43:50+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/fda-fast-track-designation-vaccine-for-celiac-disease/ 2019-01-03T11:46:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eqt-karo-pharma-694m/ 2021-11-22T06:50:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bristol-myer-sprycel-indication/ 2019-01-03T14:12:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-myokardia-acer-agreements/ 2019-01-03T12:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/companies-break-price-freeze/ 2019-01-02T12:04:50+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/aralez-drug-sale-nuvo-pharmaceuticals/ 2019-01-02T11:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mabspace-biosciences-hjb-merger/ 2019-01-02T11:45:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antengene-raises-120m/ 2019-01-02T11:46:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/population-health-outcomes-american-patients-html/ 2021-11-02T03:21:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mrna-vaccine-manufacturing/ 2018-12-17T11:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nash-market-forecast/ 2018-12-17T11:59:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anti-tau-immunotherapies-to-treat-alzheimers/ 2023-07-17T13:07:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seasons-greetings-2018/ 2018-12-26T08:35:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gsk-and-pfizer-opt-for-leaner-structure-by-merging-consumer-units/ 2018-12-21T14:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/irish-authorities-1-6bn-tax-perrigo/ 2018-12-21T13:01:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-agenus-collaboration/ 2018-12-21T10:52:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-upadacitinib-authorisations/ 2018-12-21T08:58:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-astellas-pharma-taisho-pharmaceuticals-amag-pharmaceuticals/ 2018-12-21T16:32:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-glaxosmithkline-incyte-novo-nordisk/ 2018-12-21T16:29:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquire-cellforcure/ 2018-12-21T12:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-data-and-ai-will-drive-innovation-revenue-and-operational-efficiencies-in-2019/ 2018-12-20T18:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/valsartan-update-five-months-on-and-scale-of-contamination-has-grown/ 2019-01-09T17:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-results-solo3-lynparza-cancer/ 2018-12-20T13:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/adalimumab-biosimilar-deal-to-save-the-nhs-millions/ 2018-12-20T13:36:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ifpma-code-of-practice/ 2018-12-20T11:33:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-fibrogen-roxadustat-approval-china/ 2018-12-20T10:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-imperial-ai-heart-drug-discovery/ 2023-08-11T04:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taisho-pharmaceutical-bristol-myers-upsa-offer/ 2018-12-20T09:30:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-78/ 2023-04-21T09:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-expands-recommendation-oncotype-dx/ 2019-12-23T10:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/clinical-trial-recruitment/ 2023-03-09T05:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-molecular-immune-oncology-deal/ 2018-12-19T10:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-risdiplam-prime-designation/ 2018-12-19T10:18:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-pfizer-consumer-healthcare-joint-venture/ 2018-12-19T09:50:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eastern-chinas-pharmaceutical-manufacturing-market/ 2019-06-13T14:33:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/androgen-receptor-breast-cancer-treatment/ 2018-12-18T13:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cyberattack-costs-rise/ 2023-02-22T11:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cards-of-crypto-bitcoin-gift-card/ 2019-12-23T10:52:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chimerixs-brincidofovir/ 2018-12-18T12:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/delsitech-innovare-hiv-drug/ 2018-12-18T10:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-is-it-so-hard-to-reproduce-medical-research-results/ 2018-12-13T16:33:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-innovent-biologics-licensing-deal/ 2018-12-18T09:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-staten-biotechnology-alliance/ 2022-12-01T16:55:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-ares-anti-infectives-platform/ 2018-12-18T11:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aibd-2018-development-of-a-cure-for-ibd/ 2018-12-17T15:36:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-reinsurance-model-new-therapies/ 2018-12-17T12:28:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/darzalex-results/ 2018-12-17T10:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-age-statistics/ 2018-12-17T10:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-pharmaceutical-supply-chains-disruption/ 2020-01-31T13:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-bioarctic-licensing-deal-parkinsons/ 2018-12-17T09:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-buys-potenza-therapeutics/ 2018-12-17T18:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nicox-ocumension-partnership/ 2023-06-27T04:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orchard-gene-therapy-manufacturing/ 2018-12-14T11:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rusal-ebola-vaccinations-in-guinea/ 2018-12-14T11:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-vect-horus-amgen-bristol-myers-squibb/ 2018-12-14T10:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-sanofi-lantus-patent-claims/ 2018-12-14T14:21:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bausch-health-synergy-pharmaceuticals/ 2018-12-14T11:33:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-blockchain-stem-the-tide-of-counterfeit-drugs-in-india/ 2023-02-06T07:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/brexits-impact-on-uk-life-sciences/ 2022-01-19T01:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-tremfya-plaque-psoriasis-novartis-cosentyx/ 2022-03-28T07:10:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-ac-immune-alzheimers-deal/ 2018-12-13T12:11:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-self-administration-novartis-xolair/ 2023-01-19T06:41:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-supports-hiv-research/ 2018-12-13T10:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/improving-access-medicationassisted-treatment-opioid-use-html/ 2021-11-02T03:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/incretin-combination-breakthrough-for-type-2-diabetes/ 2023-06-05T04:13:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biopharmaceutical-manufacturing-how-to-keep-your-process-safe/ 2018-12-12T14:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/congo-ebola-outbreak-vaccines/ 2021-08-11T11:52:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gardp-eisai-takeda-alliance/ 2018-12-12T10:45:17+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/vect-horus-and-johnson-johnson-partner-on-neurodegenerative-disease-treatment/ 2018-12-12T13:01:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-magellan-partnership/ 2018-12-12T13:02:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-zealand-legalise-medical-cannabis/ 2018-12-11T17:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/glaxosmithkline-drug/ 2018-12-11T16:03:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nash-therapies/ 2018-12-11T13:24:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ebola-outbreak-2018-vaccine/ 2018-12-11T13:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/2018-automate-jobs/ 2019-12-23T10:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-vedanta-biosciences-deal/ 2018-12-11T09:33:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-uk-functional-genomics-centre/ 2018-12-11T11:32:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-e-therapeutics-alliance/ 2018-12-11T13:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/major-depressive-disorder-treatment/ 2018-12-10T17:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fmx103-sunburn-impact/ 2018-12-10T17:28:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-ceo-roche-oday/ 2018-12-10T10:49:25+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/foreign-pharma-companies-china/ 2021-10-27T12:49:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disease-x-vaccines-project/ 2018-12-10T12:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fresenius-abandon-akorn-merger/ 2021-11-23T09:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-cyclica-ai-based-screening/ 2018-12-10T09:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-spin-off-speciality-generics-business/ 2018-12-07T14:20:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/revlimid-augment-trial/ 2018-12-07T13:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/quora-hack-reaction/ 2019-12-23T10:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-glaxosmithkline-takeda-procter-gamble/ 2021-10-25T09:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/november-2018-top-news-stories-pharma/ 2023-01-10T09:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/suda-zelda-partnership/ 2018-12-07T10:03:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-boehringer-ingelheim-ucb-janssen-pharmaceutical/ 2018-12-07T15:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mereo-biopharma-oncomed-pharma-merger/ 2018-12-07T09:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-tahoe-trial-rova-t-sclc/ 2023-01-25T10:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pat-informed-drug-patent-procurement-issues/ 2018-12-03T10:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-tecentriq-gets-fda-priority-review-to-treat-small-cell-lung-cancer/ 2018-12-06T12:39:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-ucl-alliance/ 2018-12-06T10:07:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-recalls-valsartan-containing-drugs/ 2018-12-06T13:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/flexible-powder-containment-ilc-dover-doverpac/ 2020-01-16T10:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/haemophilia-a-treatment-options/ 2018-12-05T14:43:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/reasons-for-clinical-trial-termination/ 2022-07-11T08:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-cancer-clinical-trials-analysis/ 2023-01-25T10:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-shareholders-approval-shire-acquisition/ 2018-12-05T11:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-domain-therapeutics-alliance/ 2018-12-05T10:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-uk-healthcare-investment/ 2018-12-05T10:22:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accelerated-approval-pathway-gbts-voxelotor-scd/ 2018-12-04T14:36:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-hodgkins-lymphoma-research/ 2018-12-04T14:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/uk-healthcare-industry-post-brexit/ 2018-12-04T15:09:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bioterrorism-threat/ 2018-12-04T14:44:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gut-health-probiotics-effectiveness/ 2018-12-04T12:03:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lyrica-generic-substitute/ 2018-12-04T15:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tech-companies-in-pharma/ 2020-01-31T13:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-report-uk-cancer-drugs-access/ 2018-12-04T12:33:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cilag-and-argenx-deal/ 2018-12-04T10:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-acquires-tesaro/ 2018-12-04T12:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pipeline-drugs-for-alzheimers/ 2018-12-03T14:22:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genetically-modified-babies-debate/ 2018-12-03T13:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-osteoarthritis-medications/ 2018-12-03T13:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/antimicrobial-resistance-superbugs/ 2023-01-06T13:38:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-adalimumab-biosimilar-agreements/ 2018-12-03T11:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pg-mercks-consumer-health/ 2021-10-25T09:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-zolgensma-application/ 2018-12-03T12:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/serialisation-impact-on-drug-manufacturers/ 2018-12-10T13:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genome-sequencing-price-drop/ 2018-11-30T14:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-alzheimers-disease-vaccine/ 2018-11-30T14:40:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gdpr-fines-payoffs/ 2019-12-23T10:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/technology-predictions-for-2019/ 2019-12-23T10:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/smartwatch-prices-wearables-growth/ 2023-05-15T05:29:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/project-dragonfly-google/ 2019-12-23T10:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gene-therapy-parkinsons-disease/ 2018-11-30T12:13:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-searchlight-pharma-q-biomed/ 2018-11-30T11:48:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-hutchison-sintilimab-fruquintinib/ 2018-11-30T12:26:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pregnancy-risk-cardiovascular-disease/ 2018-11-30T10:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-sun-pharma-genentech-cvs-health/ 2018-11-30T11:56:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hiber-nanosatellites-launch-2/ 2019-12-23T10:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-potentially-game-changing-for-synthetic-biology-study-finds/ 2019-12-23T10:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/business-digital-asset-spend/ 2019-12-23T10:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/piramal-divestiture-growth-stagnates/ 2018-11-30T15:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/strengthening-dollar-us-cmo-competitiveness/ 2018-11-29T14:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hedgehog-pathway-inhibitor/ 2023-03-08T09:51:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brexit-and-the-healthcare-industry/ 2018-11-29T12:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-approval-delstrigo-pifeltro/ 2018-11-29T15:21:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/x4-pharmaceuticals-agreement-arsanis/ 2018-11-29T11:18:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cvs-health-acquisition-aetna/ 2023-02-23T05:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cabp-therapy-lefamulin/ 2018-11-29T10:28:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/how-will-brexit-affect-healthcare/ 2022-01-19T01:36:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/industry-experts-believe-external-reference-pricing-is-coming-to-the-us/ 2018-11-28T15:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gibraltar-blockchain-exchange/ 2019-12-23T10:56:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gdpr-six-months/ 2019-12-23T10:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-genentech-jecure-therapeutics/ 2018-11-29T10:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-ziextenzo/ 2022-12-01T17:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-acquire-pola-pharma/ 2018-11-28T10:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/humira-faces-intense-biosimilar-competition-html/ 2024-11-26T10:49:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/orphan-drugs-in-2017/ 2018-11-30T17:10:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/magic-mushrooms-cure-depression/ 2018-11-27T11:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/c4x-discovery-drug-partnership-lifearc/ 2018-11-27T12:08:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuformix-agreement-nsb-nxp001/ 2018-11-27T15:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-odd-for-astrazenecas-fasenra-to-treat-egpa/ 2018-11-29T10:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-pelmeg-febrile-neutropenia/ 2022-12-01T17:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fluidic-analytics-gains-funding-for-lab-tools-products-launch/ 2018-11-26T15:51:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-chatbot-health-queries/ 2018-11-26T12:33:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/twitter-bots-catalan/ 2019-12-23T10:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/best-airports-for-remote-working/ 2019-12-23T10:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/f2g-biotech-anti-fungal-drug/ 2018-11-26T10:21:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/camuruss-buvidal-opoid-dependency/ 2018-11-23T10:53:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-daurismo-acute-myeloid-leukemia/ 2018-11-23T10:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-this-week-mundipharma-ligand-pharmaceuticals/ 2018-11-23T09:39:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-this-week-sinclair-pharma-direct-biologics/ 2021-10-27T12:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/scorpion-venom-benefits/ 2018-11-22T12:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/express-scripts-story-super-pharmacies-us-drug-industry/ 2018-11-23T08:25:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-grants-odd-for-obi-pharmas-obi-888/ 2018-11-22T12:43:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/effective-containment-systems-for-high-potency-active-pharmaceutical-ingredients-hp-apis/ 2020-01-16T10:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-sub-license-vamorolone/ 2018-11-22T11:35:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esmo-partnership-asian-european/ 2018-11-22T11:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-77/ 2023-04-12T06:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cybersecurity-trends-for-2019/ 2019-12-23T10:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/future-of-pfizers-lyrica/ 2018-11-21T11:55:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/topical-gene-therapy-trial/ 2022-12-07T14:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cambrex-acquire-avista-pharma/ 2018-11-21T11:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-gets-conditional-ec-approval-for-62bn-shire-acquisition/ 2018-11-21T11:06:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobis-gamifant-primary-hlh/ 2018-11-21T12:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lack-female-participants-skewing-heart-disease-trial-results/ 2018-11-26T10:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-partners-fuji-pharma-biosimilar-portfolio-commercialisation-japan/ 2018-11-20T14:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roivant-intron-sal200/ 2018-11-21T00:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-palantir-cancer-research/ 2018-11-20T15:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-malaria-report-2018-new-approach/ 2018-11-19T16:11:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aimmune-peanut-allergy-ar101/ 2022-12-09T12:36:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gain-act-stimulating-antibiotic-rd/ 2018-11-19T12:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jefferies-healthcare-conference-2018-sobi-bets-haemophilia-market/ 2018-11-19T12:03:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-beigene-emerge-first-chinese-immuno-oncology-leader/ 2018-11-19T11:04:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/blockchain-backed-secure-document-transfer-replace-paper/ 2018-11-28T09:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-epizyme-collaboration/ 2021-11-25T11:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-amicus-prix-galien/ 2018-11-20T12:45:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mundipharma-invossa-osteoarthritis/ 2018-11-20T12:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/verily-alcon-glucose-sensing-lens/ 2023-01-19T06:13:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-imfinzi-fails-stage-iv-lung-cancer/ 2018-11-16T15:02:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unreal-engine-gaming-ground-breaking-cures/ 2018-11-16T14:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/flexible-working-teleware/ 2019-12-23T10:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/business-byod-security-fears/ 2019-12-23T10:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/big-data-in-business/ 2019-12-23T10:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/phishing-rsa-report/ 2019-12-23T10:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/display-name-deception-top-10-brands/ 2019-12-23T10:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-nestle-health-invagen-takeda/ 2018-11-16T12:19:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-mission-therapeutics-alliance/ 2018-11-19T10:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-swedish-orphan-biovitrum-vectura/ 2018-11-16T10:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/united-arena-pharmaceuticals-deal/ 2021-12-02T07:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-staff-shortage/ 2018-11-20T12:46:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/antibiotic-awareness-who/ 2018-11-15T18:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/kpmg-privacy-concerns-gdpr/ 2019-12-23T10:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/workplace-automation-robot-boss/ 2019-12-23T10:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/draft-brexit-withdrawal-agreement-pharmaceutical/ 2018-11-15T12:26:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/apellis-unlikely-resume-amd-trial-2019/ 2022-07-11T08:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-drug-combination-therapy/ 2018-10-29T18:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elsevier-cloud-based-platform-ai/ 2019-12-23T10:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-loses-lyrica-patent-case/ 2023-01-10T09:45:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-agrees-review-roches-tecentriq/ 2018-11-15T10:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/south-korea-ruling-samsung-biologics-accounting-violations/ 2018-11-14T14:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/zafgen-t2d-obesity/ 2023-05-19T04:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/diabetes-awareness-month-unmet-needs-remain/ 2023-05-08T05:29:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-buys-us-rights-synagis/ 2018-11-14T11:15:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invagen-acquire-avenue-therapeutics-215m/ 2018-11-14T09:31:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genomic-profiling-rare-cancer-treatment/ 2018-11-14T11:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/2018-ispor-europe-research-irp-html/ 2021-11-02T03:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pricing-and-reimbursement-research-ispor-europe-html/ 2021-11-02T03:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genomic-study-link-obesity-and-depression/ 2019-12-23T10:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/humira-eu-outlook/ 2018-11-13T14:31:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mdma-assisted-psychotherapy-ptsd/ 2018-11-13T13:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-diabetes-day-cv-risk-type-2-diabetes/ 2023-06-05T04:14:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/personalised-meds/ 2018-10-24T15:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nestle-health-increases-stake-aimmune-therapeutics/ 2018-11-13T13:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/differences-global-antibiotics-use/ 2018-11-20T12:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-no-deal-brexit-costs/ 2018-11-20T12:48:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nhs-ai-investment-area/ 2019-12-23T10:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/workplace-stress-epidemic/ 2019-12-23T10:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/tim-berners-lee-fix-the-web/ 2019-12-23T10:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-in-healthcare-nhs-uk-government/ 2019-12-23T10:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/flexible-working-9-to-5/ 2019-12-23T10:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lexicon-sanofis-zynquista-divides-experts-fda-approval-prospects-t1d/ 2018-11-12T15:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsk-shingrix-blockbuster-2018/ 2018-11-12T13:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sandoz-abandons-us-rixathon-plans-focus-lucrative-markets/ 2018-11-12T13:44:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alexions-soliris-price-premium/ 2018-11-12T13:37:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sets-date-shareholder-egm-acquisition-shire/ 2018-11-12T12:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/problem-drug-patents-can-new-global-approach-help/ 2018-11-12T12:09:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-antibiotic-awareness-week-pharma-packaging-amr/ 2018-11-12T11:37:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-theraputics-maxcyte-deal/ 2019-12-23T10:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asterias-biotherapeutics-merge-biotime/ 2022-03-24T09:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-lynparza-fda-review/ 2018-11-12T12:10:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ispor-europe-2018-barcelona-html/ 2021-11-02T03:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/margrethe-vestager-digital-world-rules/ 2019-12-23T10:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hsbc-data-breach-consumer-trust/ 2019-12-23T10:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/blockchain-cybersecurity-businesses/ 2019-12-23T10:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/workplace-productivity/ 2019-12-23T10:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-strategy-microsoft/ 2019-12-23T10:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/national-quantum-computing-centre/ 2019-12-23T10:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-recalls-losartan-batch/ 2021-11-22T08:37:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-jazz-pharmaceuticals-vyxeos/ 2018-11-09T10:44:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-alexion-pharmaceutical-ovascience/ 2018-11-09T09:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vectura-hikma-ellipta-generic-versions/ 2022-12-01T04:09:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-astrazeneca-yuhan-bristol-myers/ 2021-12-02T05:26:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lung-cancer-awareness-month-highlights-tumour-testing-early-detection/ 2018-11-08T17:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/foamix-top-line-results-rosacea/ 2022-12-07T14:13:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-india-lead-tooth-decay-clinical-trials/ 2018-11-08T11:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cabometyx-and-keytruda-are-fda-approvable-in-liver-cancer-but-market-obstacles-remain/ 2018-11-08T11:27:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-digital-marketing-looks-take-personalised-approach/ 2018-11-08T11:08:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/microbiome/ 2021-09-09T16:19:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-atopic-dermatitis/ 2018-11-08T09:33:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-drug-ponatinib-use-ccm/ 2018-11-08T11:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/rapid-changes-in-the-global-irp-environment-html/ 2021-11-02T03:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-data-highlights-fastest-growing-prostate-cancer-patient-segment/ 2018-11-07T12:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spain-nolotil-british-deaths/ 2018-11-07T12:15:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/therapy-enrolment-trials/ 2018-11-07T12:04:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-covis-pharma-deal/ 2018-11-07T10:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/provention-bio-amgens-partnership/ 2018-11-07T09:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/october-2018-top-news-stories-pharma/ 2018-11-08T11:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-bavencio-faces-uncertain-future-crowded-1l-arcc-setting/ 2018-11-06T16:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/exosome-trials/ 2022-07-11T08:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alzheimers-disease/ 2018-11-06T15:22:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-merck-top-first-line-metastatic-head-neck-cancer/ 2022-02-08T13:14:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fiercebiotech-executive-summit-brexit-remains-major-concern-uk-pharma/ 2018-11-06T13:52:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-trulicity-shows-superiority-reducing-cv-events-type-2-diabetes/ 2018-11-06T12:31:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scotland-seeks-answers-brexit-costs-nhs/ 2018-11-06T10:16:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sementis-enesi-pharma-alliance/ 2018-11-06T12:17:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ecdc-drug-resistant-superbugs-report/ 2018-11-06T10:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/mexico-facing-smaller-healthcare-tender-html/ 2021-11-02T03:22:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/drug-targets-will-drive-obesity-market-next-decade/ 2023-04-12T06:59:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-artificial-intelligence-help-pharma/ 2022-02-16T04:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-single-dose-xofluza-compete-tamiflu-generics/ 2018-11-05T15:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cancer-trials-biomarkers/ 2022-07-11T08:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nurocor-partners-intilaris-improve-clinical-trial-planning-process/ 2022-07-11T08:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-bayer-shows-still-worthy-competitor-oncology/ 2018-11-05T10:58:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/yuhan-janssen-licensing-deal/ 2021-12-02T05:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gw-epidiolex-us-launch/ 2021-11-22T07:36:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-denali-therapeutics-deal/ 2018-11-05T11:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-vertex-symkevi-cystic-fibrosis/ 2018-11-05T14:09:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sandozs-biosimilar-of-humira/ 2018-11-02T12:00:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-study-debunks-emerging-flu-vaccine-myth/ 2018-11-02T10:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/entyvio-takeda-shire-merger/ 2018-11-01T17:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pancreatic-cancer-halozyme/ 2018-11-01T17:49:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-jw-pharmaceutical-lonza-karo-intressenter/ 2018-11-02T12:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-job-cut-1300-employees/ 2018-11-02T11:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-ose-immunotherapeutics/ 2018-11-02T11:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-partners-tango-therapeutics/ 2021-10-27T09:52:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-novartis-eli-lilly-astrazeneca/ 2021-11-25T10:45:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-viiv-healthcare-positive-results-hiv-treatments/ 2018-11-01T15:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/implications-of-no-deal-brexit-access-medicines-industry-lords-committee/ 2018-11-01T12:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-novartis-nash-partnership/ 2023-05-17T04:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sun-pharmas-ilumya-poised-make-waves-psoriasis-market/ 2018-11-01T10:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-opdivo-yervoy-gentler-first-line-option-mcrc/ 2018-11-01T10:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/movember-testicular-cancer-treatments/ 2018-11-01T10:09:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/selling-cells-car-t-therapy/ 2022-03-23T10:39:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-ec-approval-venclyxto-cll/ 2018-11-01T12:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-drug-research-projects-ceased/ 2018-11-01T12:08:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-strongbridge-macrilen-deal/ 2018-11-01T09:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nonsquamous-nsclc-roche-makes-strong-claim-keytrudas-leftovers/ 2018-10-31T11:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/psychedelic-microdosing-true-potential-mental-health/ 2018-10-31T11:35:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/first-flu-therapy-20-years/ 2018-10-31T11:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-invokana-reduces-cv-events-risk/ 2018-10-31T11:32:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-signs-922m-licensing-deal-grunenthal/ 2018-11-01T06:45:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-funding-boost-nhs/ 2018-10-31T12:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-q3-results-growth-innovative-health/ 2018-10-30T14:48:16+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/vitamin-supplements-do-we-need-them/ 2018-12-05T11:49:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/will-biosimilar-launches-send-humira-tumbling-europe/ 2018-10-30T11:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cancer-immunotherapy-market-growing-fast/ 2018-10-30T11:46:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ada-scid-40-years-research-set-valuation/ 2018-10-30T12:09:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/clinical-trial-transparency-americas/ 2018-10-30T09:32:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-dicerna-pharmaceuticals-deal-rnai/ 2018-10-30T11:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-pfizer-nash-therapy/ 2023-06-01T10:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scotland-pharmaceutical-sector-worth-economy-report/ 2018-10-30T11:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-combination-hrt-hot-flushes-menopause/ 2022-12-02T15:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-bavencio-arcc-setting/ 2018-10-29T15:02:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pipeline-neuro-immunology-drugs/ 2018-10-29T14:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/challenging-top-seller-first-humira-biosimilars-arrived/ 2018-10-29T12:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbott-abbvie-settle-tricor/ 2021-11-01T08:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jw-pharmaceutical-invests-british-anti-cancer-drugs-developer/ 2018-10-29T12:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-vaccines-facility-netherlands/ 2018-10-29T09:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brexit-will-impact-drug-packaging-many-pharma-firms-unaware/ 2018-10-26T15:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-q3-results-5-revenue-growth-primarily-driven-oncology/ 2018-10-26T14:32:20+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/biolive-cell-gene-therapy/ 2018-10-26T13:39:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-approves-hpv-vaccine-older-adults-us/ 2018-10-26T13:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jim-miller-cdmo/ 2018-10-26T13:23:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-gene-census-personalised-medicine/ 2018-10-26T09:23:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-cuts-price-repatha/ 2018-10-26T09:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-novartis-takeda-dechra-pharmaceuticals/ 2021-10-25T12:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-enterome-galapagos-astrazeneca/ 2018-10-26T09:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-lowers-medicare-drug-prices/ 2018-10-26T09:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-76/ 2023-04-12T06:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nyas-2018-fighting-antibacterial-resistance-lab-beyond/ 2018-10-25T14:39:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covance-definiens-ai/ 2018-10-25T12:59:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-acr-arhp-highlights-rise-registry-captures-key-trends-ra-treatment/ 2018-10-25T10:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aclaris-phase-ii-results-alopecia-drugs-may-lack-cosmetic-significance/ 2021-12-02T12:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-arc-arhp-highlights-filgotinib-excels-difficult-treat-ra-patients/ 2018-10-25T10:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brain-fingerprint-personalised-medicine/ 2019-12-23T10:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-influenza-drug-xofluza/ 2018-10-25T15:40:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-signs-bipartisan-opioid-bill/ 2018-10-25T12:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-crackdown-fake-medicines/ 2018-10-25T10:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-practical-treatment-de-escalation-early-breast-cancer/ 2018-10-24T15:32:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-hope-for-better-outcomes-in-alk-ros1-ntrk-fusion-positive-nsclc/ 2018-10-24T15:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/upadacitinib-jak-inhibitor-market/ 2018-10-24T14:09:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-acr-arhp-peficitinib-rollout/ 2018-10-24T13:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/genetic-studies-testing-combination-therapies/ 2019-12-23T10:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/public-stockpile-drugs-no-deal-brexit/ 2018-10-24T10:21:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-innate-pharma-alliance/ 2018-10-24T10:23:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-cerevel-therapeutics/ 2018-10-24T09:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncotype-dx-genomic-test-reduce-chemotherapy-recommendations/ 2018-10-23T14:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-polio-day-eradication/ 2018-10-23T14:18:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/2018-acr-arhp-etanercept/ 2018-10-23T10:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/peficitinib-safe-effective/ 2018-10-23T16:25:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-reports-positive-results-impower130-study-tecentriq/ 2018-10-23T08:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-warn-no-deal-brexit-impacts/ 2018-10-23T11:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/childhood-obesity-risk-factor-scfe/ 2018-10-23T11:35:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-opdivo-yervoy-combination-melanoma/ 2018-10-22T15:31:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/drugs-celery-genetic-engineering-can-resolve-deadly-interaction/ 2018-10-22T14:47:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/narcolepsy-drug-fda-orphan-status/ 2021-11-22T13:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/maharashtras-busy-cmo-sector/ 2018-10-22T13:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fda-approval-dupixent-asthma/ 2018-10-22T10:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-trial-ovarian-cancer/ 2018-10-22T10:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palbociclib-breast-cancer-trial/ 2022-07-11T08:55:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ipsen-seeks-candidates-looks-spend-e1bn-pipeline-growth/ 2018-10-19T14:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reimbursing-cancer-drugs-varies-europe/ 2018-10-19T11:21:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rejection-appeal-the-pfizer-australia-lipitor-case/ 2018-10-19T09:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-eisai-pharmaceutical-abbvie-otsuka/ 2018-10-19T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-emergent-biosolutions-pediapharm-adynxx/ 2018-10-23T11:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquires-endocyte-2-1bn/ 2018-10-19T08:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-gets-japanese-approval-62bn-shire-acquisition/ 2018-10-19T13:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alzheimers-trial-2019/ 2022-07-11T08:55:37+00:00 daily 0.2